Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika E Hegi

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Current Opinion in Neurology|October 25, 2013
Molecular insights into brain tumors: ready for translation into novel treatment strategies?Monika E Hegi
Nature Biotechnology|February 9, 2007
Targeting brain-tumor stem cellsRoger Stupp, Monika E Hegi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Methylguanine methyltransferase testing in glioblastoma: when and how?Roger Stupp, Monika E Hegi
The Lancet. Neurology|December 15, 2006
Neuro-oncology: oligodendroglioma and molecular markersRoger Stupp, Monika E Hegi
Seminars in Cancer Biology|November 25, 2017
Glioma epigenetics: From subclassification to novel treatment optionsOlga Gusyatiner, Monika E Hegi
Neuro-Oncology|July 9, 2021
MGMT testing always worth an emotionMonika E Hegi, Koichi Ichimura
Neuro-Oncology|September 17, 2015
Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?Monika E Hegi, Roger Stupp
Current Oncology Reports|February 9, 2006
Correlative studies in neuro-oncology trials: should they influence treatment?Monika E Hegi, Roger Stupp
Nature Reviews. Neurology|July 3, 2013
Neuro-oncology: in search of molecular markers of glioma in elderly patientsMonika E Hegi, Roger Stupp
Nature Reviews. Clinical Oncology|January 9, 2013
Brain cancer in 2012: Molecular characterization leads the wayRoger Stupp, Monika E Hegi
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Current Opinion in Neurology|October 25, 2013
Molecular insights into brain tumors: ready for translation into novel treatment strategies?Monika E Hegi
Nature Biotechnology|February 9, 2007
Targeting brain-tumor stem cellsRoger Stupp, Monika E Hegi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Methylguanine methyltransferase testing in glioblastoma: when and how?Roger Stupp, Monika E Hegi
The Lancet. Neurology|December 15, 2006
Neuro-oncology: oligodendroglioma and molecular markersRoger Stupp, Monika E Hegi
Seminars in Cancer Biology|November 25, 2017
Glioma epigenetics: From subclassification to novel treatment optionsOlga Gusyatiner, Monika E Hegi
Neuro-Oncology|July 9, 2021
MGMT testing always worth an emotionMonika E Hegi, Koichi Ichimura
Neuro-Oncology|September 17, 2015
Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?Monika E Hegi, Roger Stupp
Current Oncology Reports|February 9, 2006
Correlative studies in neuro-oncology trials: should they influence treatment?Monika E Hegi, Roger Stupp
Nature Reviews. Neurology|July 3, 2013
Neuro-oncology: in search of molecular markers of glioma in elderly patientsMonika E Hegi, Roger Stupp
Nature Reviews. Clinical Oncology|January 9, 2013
Brain cancer in 2012: Molecular characterization leads the wayRoger Stupp, Monika E Hegi
Pageof 11